Description

Credits (Post Test and/or Evaluation Required)

0.99 - Contact Hours

0.09 - Pharmacology

Release Date: 9/16/2019

Expiration Date: 9/16/2021

Credit Information:

Nurses – ANCC and CBRN Accreditation Statements

The Wound, Ostomy and Continence Nurses Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The Wound, Ostomy and Continence Nurses Society is approved by the California Board of Registered Nursing, Provider Number CEP 15115.

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN or WOCN Society endorsement of any commercial product or service.

Target Audience: 

RN, Nurse Practitioners, Health Care Professionals who work with WOC patients.

To Receive Credit:

1. Complete the activity in its entirety.
2. Complete/submit the evaluation.
3. Print out your certificate and/or save to your computer. It will also be saved to your CEC account.

Program Overview:

This session will cover the evaluation and treatment of urinary retention, especially in the female, with emphasis on neurogenic bladder. Urinary retention is a poorly understood condition. Though the causation is generally attributed to either bladder or bladder outlet dysfunction, and an accurate diagnosis is often straightforward, it remains an under diagnosed condition. Treatment is dependent on the underlying causation. Often felt by the medical community to be extraordinarily complex, this session will outline a straight forward approach to the diagnosis and treatment options for the condition.

Learning Objectives:

• Learners will develop a clear and concise approach to the diagnosis and treatment of urinary retention in the neurogenic patient.

Disclosures:

The planners and faculty for this session reported no relevant relationships with commercial interest organizations. This presentation was reviewed to ensure no bias was present.

The planners and faculty for this program have nothing to disclose unless listed below. All potential Conflicts of Interest have been reviewed by the Lead Nurse Planner, Nurse Planner, and Director of Education, and resolved according to the WOCN Society policy to ensure that no bias exists as a result of disclosed relevant financial relationships with Commercial Interest Organizations.

• Eric Rovner: Allergan: consultant, study investigator; Astellas: consultant, study investigator; Ferring: consultant; NIH/NIDDK: grant support

Commercial Support or Non-Commercial Sponsorship:

There is no commercial support or non-commercial sponsorship for this activity.

Speaker(s):

• Dr. Eric S. Rovner, MD, Professor of Urology, MUSC

Category: Continence